Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Excess muscle plasma membrane leak disrupts ECM content and shifts macrophage-mediated muscle repair
GaHyun Lee, Alexander J. Fitt, Ashlee M. Long, Lauren A. Vaught, Dorothy DeBiasse, Alexander R. Keeble, Jason M. Kwon, Patrick G.T. Page, Marie-Therese Daher, Michele Hadhazy, Alexander B. Willis, David Ceja Galindo, Maxwell McCabe, Connor Lantz, Kirk C. Hansen, Rachelle H. Crosbie, Edward B. Thorp, Alexis R. Demonbreun, Elizabeth M. McNally
GaHyun Lee, Alexander J. Fitt, Ashlee M. Long, Lauren A. Vaught, Dorothy DeBiasse, Alexander R. Keeble, Jason M. Kwon, Patrick G.T. Page, Marie-Therese Daher, Michele Hadhazy, Alexander B. Willis, David Ceja Galindo, Maxwell McCabe, Connor Lantz, Kirk C. Hansen, Rachelle H. Crosbie, Edward B. Thorp, Alexis R. Demonbreun, Elizabeth M. McNally
View: Text | PDF
Research Article Inflammation Muscle biology

Excess muscle plasma membrane leak disrupts ECM content and shifts macrophage-mediated muscle repair

  • Text
  • PDF
Abstract

Plasma membrane repair is critical for tissue integrity, especially for elongated contractile muscle cells. Genetically mediated defects in plasma membrane resealing produce persistent leak, leading to a disordered extracellular matrix (ECM). Loss of the membrane repair protein dysferlin slows sarcolemmal resealing and promotes excess leak. Annexin A6 is also implicated in sarcolemmal repair, forming repair caps at the site of membrane disruption. On its own, deletion of the gene for annexin A6, Anxa6, had little effect on muscle health. In contrast, combined loss of dysferlin and annexin A6 (DysfA6) generated muscle fibers with profoundly defective membrane leak. Strikingly, Anxa6 deletion in the context of loss of dystrophin (mdxA6) did not exacerbate muscle defects. The persistent membrane leak in DysfA6 muscle resulted in marked macrophage infiltration with disordered macrophage polarization. Injured muscle fibers were targets of macrophage efferocytosis. Loss of Anxa6 was associated with increased expression of annexins A1 and A2, both of which were heavily deposited into the ECM. In vitro, macrophages exposed to annexins A1 and A2 increased Csf1 expression, consistent with a model where excess leak results in annexins A1 and A2 in the ECM, where this protein composition influences macrophage proliferation and efferocytosis.

Authors

GaHyun Lee, Alexander J. Fitt, Ashlee M. Long, Lauren A. Vaught, Dorothy DeBiasse, Alexander R. Keeble, Jason M. Kwon, Patrick G.T. Page, Marie-Therese Daher, Michele Hadhazy, Alexander B. Willis, David Ceja Galindo, Maxwell McCabe, Connor Lantz, Kirk C. Hansen, Rachelle H. Crosbie, Edward B. Thorp, Alexis R. Demonbreun, Elizabeth M. McNally

×

Figure 7

Increased ANXA1 and ANXA2 in DysfA6 muscle and in decellularized myoscaffolds from Dysf muscle.

Options: View larger image (or click on image) Download as PowerPoint
Increased ANXA1 and ANXA2 in DysfA6 muscle and in decellularized myoscaf...
(A) A comparison of proteomic profiles from the CHAPS/NaCl-soluble cellular fraction of WT, Dysf, and DysfA6 muscle shows expansion of ECM-associated proteins (n = 6–7 mice per genotype). (B) Differentially expressed proteins between DysfA6 and WT in the CHAPS/NaCl-soluble cellular and guanidine-HCl–soluble (Gnd-HCl-soluble) ECM fractions of the muscle. (C and D) ANXA1 and ANXA2 were increased in both the CHAPS/NaCl- and Gnd-HCl–soluble fractions of DysfA6 compared with Dysf and WT (n = 6–7 mice per genotype). (E) Immunoblot of whole muscle lysates for ANXA1 and ANXA2 confirmed greater expression in the presence of defective repair. (F and G) Muscle sections were decellularized to generate myoscaffolds and visualize ECM-associated proteins. Increased ANXA1 and ANXA2 deposition was seen in decellularized myoscaffolds of DysfA6 compared with WT and Dysf by IFM. **P < 0.01; ***P < 0.005; ****P < 0.001 by 1-way ANOVA followed by Tukey’s multiple comparisons test. Scale bars: 100 μm.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts